Eli Lilly said it will apply for U.S. health regulator's accelerated approval this year for its experimental Alzheimer's drug, weeks after Biogen's controversial drug for the disease was approved https://t.co/pgBomedSMn pic.twitter.com/tNWZtND2qt— Reuters (@Reuters) June 24, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


